COVID-19 and antiphospholipid antibodies

A Butt, D Erkan, AI Lee - Best Practice & Research Clinical Haematology, 2022 - Elsevier
Antiphospholipid syndrome and the coagulopathy of COVID-19 share many
pathophysiologic features, including endotheliopathy, hypercoagulability, and activation of …

Systematic review of antiphospholipid antibodies in COVID-19 patients: culprits or bystanders?

T Foret, V Dufrost, L Salomon Du Mont, P Costa… - Current Rheumatology …, 2021 - Springer
Purpose of Review COVID-19 patients have a procoagulant state with a high prevalence of
thrombotic events. The hypothesis of an involvement of antiphospholipid antibodies (aPL) …

Age-associated neurological complications of COVID-19: a systematic review and meta-analysis

BN Sullivan, T Fischer - Frontiers in aging neuroscience, 2021 - frontiersin.org
The outbreak of the novel and highly infectious severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2) has resulted in hundreds of millions of infections and millions …

[PDF][PDF] COVID-19 related acute hemorrhagic necrotizing encephalitis: a report of two cases and literature review

N Mullaguri, S Sivakumar, A Battineni, S Anand… - Cureus, 2021 - cureus.com
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), a novel coronavirus, has proven neurotropism and causes a …

New directions in infection-associated ischemic stroke

JM Jung, A Gruber, P Heseltine… - Journal of Clinical …, 2024 - pmc.ncbi.nlm.nih.gov
The relationship between infections and stroke has not been fully characterized, probably
delaying the development of specific treatments. This narrative review addresses …

Mortality rate and biomarker expression within COVID-19 patients who develop acute ischemic stroke: a systematic review and meta-analysis

A Yassin, A Ghzawi, AH Al-Mistarehi… - Future Science …, 2021 - Taylor & Francis
Objective: To describe the mortality difference between acute ischemic stroke (AIS) and non-
AIS groups within COVID-19 patients. Materials & methods: We included observational …

HDAC inhibition as neuroprotection in COVID-19 infection

Y Sixto-López, J Correa-Basurto - Current topics in medicinal …, 2022 - benthamdirect.com
The SARS-CoV-2 virus is responsible for COVID-19 affecting millions of humans around the
world. COVID-19 shows various clinical symptoms (fever, cough, fatigue, diarrhea, body …

Candida pneumonia with lung abscess as a complication of severe COVID-19 pneumonia

A Abdelhadi, A Kassem - International medical case reports journal, 2021 - Taylor & Francis
A South Asian male patient in his mid-forties presented with symptoms of severe 2019-nCoV
(COVID-19) and recent brain infarction. Subsequently, he was found to have evidence of …

Antiphospholipid Antibodies and COVID‐19: A Systematic Review of Clinical Implications

T Sabaghian, AB Kharazmi, F Omidi… - Immunity …, 2025 - Wiley Online Library
Introduction As the COVID‐19 pandemic transitions, understanding the intricate dynamics of
the disease becomes paramount. This systematic review explores the role of …

[HTML][HTML] Acute stroke in COVID-19 patients: A first year experience in a Colombian hospital

NC Blanco, CAR Hernández, JV Fernández - Neurology Perspectives, 2023 - Elsevier
Background COVID-19 may be a new risk factor for stroke. Stroke in COVID-19 varies from
1.1 to 8.1%. Various pathophysiological pathways predispose SARS-CoV-2 infected …